136. Creutzberg CL, van Putten WL, W´arl´am-Rodenhuis CC, et al. Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial. J Clin Oncol 2004;22:1234– 1241.
137.
Mariani A, Webb MJ, Keeney GL, et al. Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary? Am J Obstet Gynecol 2000;182:1506–1519.
138.
Benedetti Panici P, Basile S, Maneschi F, et al. Systematic pelvic lymphadenectomy vs no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst 2008;100:1707–1716.
139.
Kitchener H, Swart AM, Qian Q, et al. ASTEC Study Group. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 2009;373:125– 136.
140.
Mariani A, Dowdy SC, Cliby WA, et al. Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol Oncol 2008;109:11–18.
141.
Creasman WT, Morrow CP, Bundy BN, et al. Surgical pathologic spread patterns of endometrial cancer: a Gynecologic Oncology Group Study. Cancer 1987;60:2035–2041.
142.
Schink JC, Lurain JR, Wallemark CB, et al. Tumor size in endometrial cancer: a prognostic factor for lymph node metastasis. Obstet Gynecol 1987;70:216–219.
143.
Todo Y, Kato H, Kaneuchi M, et al. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet 2010;375:1165–1172.
144.
Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynecol Obstet 2009;105:103–104.
145.
Christopherson WM, Connelly PJ, Aberhasky RC. Carcinoma of the endometrium: an analysis of prognosticators in patients with favorable subtypes and stage II disease. Cancer 1983;51:1705–1709.
146.
Crissman JD, Azoury RS, Banner AE, et al. Endometrial carcinoma in women 40 years of age or younger. Obstet Gynecol 1981;57:699–704.
147.
Nilson PA, Koller O. Carcinoma of the endometrium in Norway 1957–1960 with special reference to treatment results. Am J Obstet Gynecol 1969;105:1099–1109.
148.
Zaino RJ, Kurman RJ, Diana KL, et al. Pathologic models to predict outcome for women with endometrial adenocarcinoma. Cancer 1996;77:1115–1121.
149.